Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
Glioblastoma (GB) is the most common and the most aggressive form of brain tumor in adults, which currently lacks efficient treatment strategies. In this study, we investigated the therapeutic effect of function-blocking antibodies targeting integrin α10β1 on patient-derived-GB cell lines in vitro a...
Main Authors: | Katarzyna Chmielarska Masoumi, Xiaoli Huang, Wondossen Sime, Anna Mirkov, Matilda Munksgaard Thorén, Ramin Massoumi, Evy Lundgren-Åkerlund |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/5/1184 |
Similar Items
-
Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
by: Matilda Munksgaard Thorén, et al.
Published: (2019-04-01) -
Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
by: Saidu Sani, et al.
Published: (2022-01-01) -
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
by: William Echavidre, et al.
Published: (2022-05-01) -
Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma
by: Nelly Etienne-Selloum, et al.
Published: (2021-08-01) -
Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability
by: Jinmi Zou, et al.
Published: (2022-10-01)